Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 27;120(2):e20220205.
doi: 10.36660/abc.20220205. eCollection 2023.

Outpatient 6-Hour Levosimendan Treatment as a Bridge to Heart Transplant

[Article in English, Portuguese]
António Valentim Gonçalves  1 , João Pedro Reis  1 , Ana Teresa Timóteo  1 , Rui Soares  1 , Tiago Pereira-da-Silva  1 , Valdemar Gomes  1 , Rita Ilhão Moreira  1 , Delmira Pombo  1 , Tiago Carvalho  1 , Catarina Correia  1 , Claudia Santos  1 , Rui Cruz Ferreira  1
Affiliations

Outpatient 6-Hour Levosimendan Treatment as a Bridge to Heart Transplant

[Article in English, Portuguese]
António Valentim Gonçalves et al. Arq Bras Cardiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potencial conflito de interesse

Não há conflito com o presente artigo

References

    1. Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, et al. Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail . 2018;20(11):1505–1535. doi: 10.1002/ejhf.1236. - DOI - PubMed
    1. Mebazaa A, Motiejunaite J, Gayat E, Crespo-Leiro MG, Lund LH, Maggioni AP. Long-Term Safety of Intravenous Cardiovascular Agents in Acute Heart Failure: Results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail . 2018;20(2):332–341. doi: 10.1002/ejhf.991. - DOI - PubMed
    1. Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, et al. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use. J Cardiovasc Pharmacol . 2020;76(1):4–22. doi: 10.1097/FJC.0000000000000859. - DOI - PMC - PubMed
    1. Altenberger J, Parissis JT, Costard-Jaeckle A, Winter A, Ebner C, Karavidas A, et al. Efficacy and Safety of the Pulsed Infusions of Levosimendan in Outpatients with Advanced Heart Failure (LevoRep) Study: A Multicentre Randomized Trial. Eur J Heart Fail . 2014;16(8):898–906. doi: 10.1002/ejhf.118. - DOI - PubMed
    1. Comín-Colet J, Manito N, Segovia-Cubero J, Delgado J, García Pinilla JM, Almenar L, et al. Efficacy and Safety of Intermittent Intravenous Outpatient Administration of Levosimendan in Patients with Advanced Heart Failure: The LION-HEART Multicentre Randomised trial. Eur J Heart Fail . 2018;20(7):1128–1136. doi: 10.1002/ejhf.1145. - DOI - PubMed